About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Best Way to Stop Ebola Virus - Pack a Punch of Powerful Antibodies

by Thilaka Ravi on August 10, 2018 at 6:32 PM
Font : A-A+

Best Way to Stop Ebola Virus - Pack a Punch of Powerful Antibodies

Ebola virus experts have found that the best way to stop Ebola virus is to pack a 'one-two punch of powerful antibodies'. The findings reported by an international team of scientists in the journal Cell suggest new therapies should disable Ebola virus's infection machinery and kickstart the patient's immune system to build the body's defense.

"This study presents results from an unprecedented international collaboration and demonstrates how 43 previously competing labs can together accelerate therapeutics and vaccine design," says Erica Ollmann Saphire, PhD, professor at Scripps Research and director of the Viral Hemorrhagic Fever Immunotherapeutic Consortium (VIC).

Advertisement


From 2013-2016, West Africa faced the deadliest Ebola outbreak the world has ever seen. By the time the outbreak was declared over, 11,325 people had died. The VIC is an international group of the world's leading virologists, immunologists, systems biologists and structural biologists working to stop an outbreak on that scale from ever striking again.

The VIC researchers aim to understand which Ebola-fighting antibodies are best-and why. The hope is that the most effective antibodies can be combined in a therapeutic "cocktail." Unlike an Ebola vaccine, these cocktails could be given to those already infected, which is important for stopping a disease that tends to emerge unexpectedly in remote locations.
Advertisement

Ollmann Saphire and her colleagues in the VIC have published more than 40 studies in just the last five years. This landmark study is the first-ever side-by-side comparison of 171 antibodies against Ebola virus and other related viruses, known as filoviruses. All antibodies in the panel were donated by different labs around the world, and many had not been previously characterized in such extensive detail.

"Through the VIC, we could test a larger pool of antibodies in parallel, which increased the potential to detect statistically significant relationships between antibody features and protection," says Saphire. "We used this global pool of antibodies to evaluate, and streamline, the research pipeline itself."

In addition to identifying links between antibody target locations and activity, VIC researchers tested this huge pool of antibodies to reveal which antibodies "neutralized" the virus, why neutralization assays so often disagree, and whether or not neutralization in test tubes adequately predicted how well these antibodies would protect live animals from Ebola virus infection. Unexpectedly, neutralization alone was not always associated with the protective ability of an antibody.

Notably, the scientists found nine antibodies that protected mice from infection without neutralizing the virus in test tubes. These antibodies likely fight infection by interacting with an infected person's immune system, helping orchestrate a better immune response to the virus.

This "immune effector" activity is featured in the team's companion study published simultaneously in Cell Host & Microbe. "The ability to evoke an immune response will likely represent a new avenue of study for therapeutic antibodies for Ebola virus infection," says Sharon Schendel, project manager for the VIC and science writer in the Saphire lab.

From the large body of results, VIC member and Scripps Research faculty member Kristian Andersen, PhD, and his graduate student Karthik Gangavarapu developed a network describing how each antibody feature correlates to protection, which can serve as a guide to predict whether newly identified antibodies will have therapeutic value. Saphire says the next steps for the VIC are to further test promising antibody cocktails in non-human primates. The team will also pursue engineering of antibodies that carry signature features to better drive immune system response.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Good Nutrition Linked to Better Mental Health in School Children
Convulsions / Seizures / Fits - Symptom Evaluation
World Heart Day 2021 -
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Chicken Pox Shigellosis Bioterrorism Amyotrophic Lateral Sclerosis (ALS) Congo Fever Ebola Virus Disease Acute Coronary Syndrome 

Recommended Reading
Ebola Virus Disease
Ebola is caused by a virus via direct contact with body fluids or infected blood. Scientists have .....
New Ebola Virus Antibody Paves the Way for Future Vaccines and Therapy
Natural human antibodies isolated from the blood of an Ebola survivor has been shown to neutralize ....
Interferon Drug Promises Hope for Ebola Virus Treatment
Ebola virus causes fatal illness, interferon drug may show promise for treatment, reveals study....
Phase 2 Clinical Trials of Two Candidate Ebola Vaccines in Liberia
A phase 2 clinical trial of two candidate Ebola vaccines in Liberia showed that the vaccines are ......
Acute Coronary Syndrome
Acute coronary syndrome (ACS) is a sudden, acute life-threatening condition caused by a dramatic red...
Amyotrophic Lateral Sclerosis (ALS)
Find out more about the degenerative disease- Amyotrophic lateral sclerosis....
Chicken Pox
Chicken pox is an acute and highly contagious viral infection caused by the varicella zoster virus....
Congo Fever
Crimean-Congo Hemorrhagic fever (CCHF) is a viral disease that affects people who are bitten by infe...
Shigellosis
Shigellosis or Bacillary Dysentery is a common cause of gastro-enteritis worldwide and can cause blo...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use